| P.1 Molecular neuropsychopharmacology |
| |
|
| P.1.002 |
(PDF 201 kb) |
| Drug interaction between fibrillar amyloid ß and alpha7 nicotinic receptor in Alzheimer brain |
 Ruiqing Ni, Sweden |
| |
|
| P.1.004 |
(PDF 818 kb) |
| Association of GTP-binding protein Di-Ras2 (DIRAS@) with attention-deficit / hyperactivity disorder |
| Lena Weissflog, Germany |
| |
|
| P.1.005 |
(PDF 149 kb) |
| Retinoic acid upregulates reduced cd38 transcription in lymphoblastoid cell lines from patients with autism spectrum disorder |
| Mathias Riebold, Germany |
| |
|
| P.1.006 |
(PDF 193 kb) |
| Screening for rare variants in TMEM132D: a candidate gene from genome-wide association studies in anxiety disorders |
| Carina Quast, Germany |
| |
|
| P.1.007 |
(PDF 258 kb) |
| Assessment of cellular environments on radioligand binding - an application to opioid receptor PET imaging |
| Darren Robert Quelch, United Kingdom |
| |
|
| P.1.011 |
(PDF 238 kb) |
| Evidence of hypothalamic mitochondrial dysfunction and neurodegeneration in the anorectic anx/anx mouse model |
| Ida A. K. Nilsson, Sweden |
| |
|
| P.1.013 |
(PDF 347 kb) |
| The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in rats |
| Elsmarieke van de Giessen, The Netherlands |
| |
|
| P.1.014 |
(PDF 319 kb) |
| Time-dependent alterations of the endocannabinoid system and synaptic markers following adolescent delta-9-tetrahydro-cannabinol (THC) administration in female rats |
| Erica Zamberletti, Italy |
| |
|
| P.1.015 |
(PDF 219 kb) |
| gluN2D-containing NMDA receptors in cholinergic interneurons control dopamine release in the mouse striatum |
| Xiaoqun Zhang, Sweden |
| |
|
| P.1.017 |
(PDF 933 kb) |
| Characterisation of the fast acting antidepressant LuAA21004: key role for the 5-HT3 receptor blockade |
| Cecile Betry, France |
| |
|
| P.1.019 |
(PDF 246 kb) |
| Olanzapine-induced weight gain is associated with increased hypothalamic ghrelin receptor expression |
| Harriet Schellekens, Ireland |
| |
|
| P.1.020 |
(PDF 733 kb) |
| Selective ablation of glucocorticoid receptor in noradrenergic system of mice: the influence on brain noradrenergic receptors |
| Piotr Chmielarz, Poland |
| |
|
| P.1.022 |
(PDF 331 kb) |
| Epigenetic modifications in transgenic mouse with human polymorphism (Val66Met) of BDNF gene |
| Stefano Corna, Italy |
| |
|
| P.1.023 |
(PDF 1.853 kb) |
| Influence of afobazol on neuromediator amino acids level in rat brain caused by global ischemia |
| Veronika Baykova, Russia |
| |
|
| P.1.024 |
(PDF 136 kb) |
| The epigenetic machinery of neural cells is modulated by psychoactive drugs |
| Nicole Zimmermann, Germany |
| |
|
| P.1.025 |
(PDF 780 kb) |
| Stress at the synapse: the synaptic action of acute behavioural stress and the protective effect of psychiatric drugs |
| Giulia Treccani, Italy |
| |
|
| P.1.026 |
(PDF 74 kb) |
| Dopamine-related gene polymorphisms in schizophrenia and in therapeutic response |
| Agnes Feher, Hungary |
| |
|
| P.1.030 |
(PDF 1.308 kb) |
| Epigenetic modification of the glucocorticoid receptor gene predicts women's salivary cortisol following a threat to the social self |
| Shany Edelman, Israel |
| |
|
| P.1.031 |
(PDF 480 kb) |
| Expression of glucose metabolism genes in a psychosis model: a molecular link between NMDA receptor hypofunction and metabolism disorders? |
| Federica Marmo, Italy |
| |
|
| P.1.032 |
(PDF 586 kb) |
| Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychoses |
| Sara Calandro, Italy |
| |
|
| P.1.036 |
(PDF 1.669 kb) |
| Antidepressants modulate human hippocampal neurogenesis by activating the glucocorticoid receptor |
| Christoph Anacker, United Kingdom |
| |
|
| |
|
| P.2 Behavioural pharmacology |
| |
|
| P.2.001 |
(PDF 1.262 kb) |
| Memantine rescues behavioural and cognitive deficits following olfactory bulbectomy in rats |
| Yuliya Borre, The Netherlands |
| |
|
| P.2.002 |
(PDF 1.146 kb) |
| 1,2,3,4-Tetrahydroisoquinoline has shown antidepressant properties in the modified rat forced swimming test |
| Edyta Mozdzen, Poland |
| |
|
| P.2.003 |
(PDF 870 kb) |
| CB1 and TRPV1 receptors located in periaqueductal gray matter mediate opposite effects in panic-like responses in rats |
| Ana Terzian, Germany |
| |
|
| P.2.005 |
(PDF 215 kb) |
| Impulsive decision making does not predict vulnerability to heroin seeking and taking |
| Maria Carolina Schippers, The Netherlands |
| |
|
| P.2.012 |
(PDF 332 kb) |
| Pattern of self-administration can influence motivation for cocaine in rats |
| Elena Martin, France |
| |
|
| P.2.016 |
(PDF 130 kb) |
| Role of topiramate on impulsive behaviour in DBA/2 mice |
| Francisco Navarrete, Spain |
| |
|
| P.2.018 |
(PDF 1.516 kb) |
| Behavioural and cognitive alterations of the young megencephaly (BALB/cByJ-Kv1.1 mceph/mceph) mouse |
| Sarah Holst, Sweden |
| |
|
| P.2.019 |
(PDF 86 kb) |
| The role of brain-derived neurotrophic factor in the antidepressant effect of desipramine and electroconvulsive treatment |
| Dekel Taliaz, Israel |
| |
|
| P.2.020 |
(PDF 490 kb) |
| AS101 antidepressant-like effects in rat models for depression |
| Hagar Saida, Israel |
| |
|
| P.2.021 |
(PDF 1.266 kb) |
| Antidepressant-like activity of Rp-8-Br-cAMPS, an inhibitor of cAMP-dependent protein kinase |
| Nico Liebenberg, Denmark |
| |
|
| P.2.023 |
(PDF 234 kb) |
| In vivo microdialysis studies of brain dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction |
| Karolina Wydra, Poland |
| |
|
| P.2.025 |
(PDF 191 kb) |
| Erasure of traumatic fear memory in mice by a combination of fluoxetine and fear extinction training |
| Jesse Lindholm, Finland |
| |
|
| P.2.027 |
(PDF 227 kb) |
| Consequences of in utero methamphetamine exposure on behaviour in the adult rat |
| Sandra O'Brien, Ireland |
| |
|
| P.2.028 |
(PDF 864 kb) |
| Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain |
| Maria Juliana Orejarena, Spain |
| |
|
| |
|
| P.3 Clinical neuropsychopharmacology |
| |
|
| P.3.001 |
(PDF 241 kb) |
| A functional magnetic resonance imaging study of schizoaffective patients versus healthy controls: preliminary data |
| Benedikt L. Amann, Spain |
| |
|
| P.3.002 |
(PDF 268 kb) |
| Differential effects of Methylphenidate and Atomoxetine on brain activation in medication-naïve children with ADHD |
| Ana Cubillo, United Kingdom |
| |
|
| P.3.003 |
(PDF 419 kb) |
| The effects of quetiapine on emotional processing |
| Philippa Rock, United Kingdom |
| |
|
| P.3.004 |
(PDF 1.168 kb) |
| Risk for adverse health outcome in antipsychotic-naïve adolescents after 12 months of treatment with second-generation antipsychotics |
| Laura Pina, Spain |
| |
|
| P.3.005 |
(PDF 338 kb) |
| N-acetylcysteine changes glutamate levels in cocaine dependent subjects: an open label [1H] MRS study |
| Lianne Schmaal, The Netherlands |
| |
|
| P.3.007 |
(PDF 278 kb) |
| Intranasal administration of arginine vasopressin selectively reduces cognitive empathy |
| Florina Uzefovsky, Israel |
| |
|
| P.3.008 |
(PDF 594 kb) |
| Predictors of response to antidepressant treatment in bipolar depression |
| Andrea Murru, Spain |
| |
|
| P.3.009 |
(PDF 1.179 kb) |
| A principal component analysis of treatment patterns according to clinical features in a naturalistic cohort study of bipolar patients |
| Alessandra Nivoli, Italy |
| |
|
| P.3.012 |
(PDF 177 kb) |
| The influence of hormone replacement therapy on the serotonin-1A receptor binding in postmenopausal women |
| Georg Kranz, Austria |
| |
|
| P.3.013 |
(PDF 160 kb) |
| Clinical features and stressful life events before development of first-episode acute transient psychosis |
| Marija Rusaka, Latvia |
| |
|
| P.3.014 |
(PDF 243 kb) |
| Cognitive bias in social alcohol consumers: do stimuli matter? |
| Alia Ataya, United Kingdom |
| |
|
| P.3.015 |
(PDF 334 kb) |
| The determining factors of orbitofrontal cortex associated decision-making skills in alcohol-dependence |
| Bálint Andó, Hungary |
| |
|
| P.3.020 |
(PDF 102 kb) |
| How ketamine changes neurophysiology of depressive patients brains: a randomised controlled trial |
| Peter Sos, Czech Republic |
| |
|
| |
|
| P.4 Schizophrenia: towards new drug targets |
| |
|
| P.4.002 |
(PDF 137 kb) |
| Catechol-o-methyltransferase (COMT) influences dopamine metabolism outside of the prefrontal cortex |
| Linda Laatikainen, United Kingdom |
| |
|
| P.4.006 |
(PDF 274 kb) |
| Expression of EGR1, EGR2 and EGR3 proteins in postmortem brain of schizophrenic subjects |
| Aintzane Garcia-Bea, Spain |
| |
|
| P.4.008 |
(PDF 429 kb) |
| Impact of the functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR) on schizophrenia and verbal memory |
| Leonhard Lennertz, Germany |
| |
|
| P.4.009 |
(PDF 638 kb) |
| Schizophrenia endophenotypes and stress hyper-reactivity co-precipitate following adverse life events in genetically susceptible rats |
| Nikolaos Daskalakis, The Netherlands |
| |
|
| P.4.010 |
(PDF 200 kb) |
| A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy |
| Ivan Koychev, United Kingdom |
| |
|
| P.4.011 |
(PDF 845 kb) |
| The role of stress and inflammation on diet and metabolic status in first-episode psychosis |
| Nilay Hepgul, United Kingdom |
| |
|
| P.4.012 |
(PDF 136 kb) |
| Changes of some oxidative stress markers in schizophrenia: comparison between typical and atypical antipsychotics effects |
| Manuela Padurariu, Romania |
| |
|
| P.4.013 |
(PDF 621 kb) |
| Association between physical activity, fitness and global brain volumes in patients with schizophrenia and matched healthy controls |
| Thomas Scheewe, The Netherlands |
| |
|
| P.4.014 |
(PDF 1.809 kb) |
| Targeting the alpha7 nicotinic receptor subtype to restore working memory deficits in rats following sub-chronic ketamine exposure |
| Samantha Rushforth, United Kingdom |
| |
|
| P.4.017 |
(PDF 1.706 kb) |
| Brain derived neurotrophic factor as a predictor of the cognition and prognosis in first episode psychosis after antipsychotic treatment |
| Sonia Ruiz De Azua Garcia, Spain |
| |
|
